Gluten content in labeled and unlabeled gluten-free food products used by patients with celiac disease
- 18 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Nutrition
- Vol. 75 (8), 1245-1253
- https://doi.org/10.1038/s41430-020-00854-6
Abstract
Objective Gluten-free (GF) diet is the only reliable treatment for patients with celiac disease (CeD), but data on the extent of gluten contamination in GF food available in India is scanty. We evaluated gluten content in labeled, imported, and non-labeled GF food products currently available in the Indian market. Methods Overall, 794 processed and commercially available packaged GF products (labeled GF (n = 360), imported GF (n = 80), and non-labeled/naturally GF (n = 354)) were collected from supermarkets of National Capital Region of India. Those unavailable in stores were purchased from e-commerce sites or directly from the manufacturers. Gluten level in them was determined by Ridascreen Gliadin sandwich R5 enzyme-linked immunosorbent assay (R-Biopharm AG, Germany). As per Codex Alimentarius and Food Safety and Standard Authority of India, “gluten free” labeled products must not contain > 20 mg/kg of gluten. Results Overall, 10.1% of 794 GF products including 38 (10.8%) of 360 labeled and 42 (11.8%) of 354 non-labeled/naturally GF food products had gluten content > 20 mg/kg (range: 24.43–355 and 23.2–463.8 mg/kg, respectively). None of the imported GF products had gluten more than the recommended limits. Contaminated products most commonly belonged to cereal and their products (flours, coarse grains, pasta/macaroni, snack foods) pulse flours, spices, and bakery items. Conclusions A substantial proportion (10.1%) of GF food products (both labeled and non-labeled) available in India have gluten content greater than the prescribed limits of <20 mg/kg. Physicians, dietitians, support group, and patients with CeD should be made aware of this fact and regulatory bodies should ensure quality assurance.Funding Information
- Indian Council of Medical Research (5/9/1179/2018-NUT, 5/9/1179/2018-NUT, 5/9/1179/2018-NUT, 5/9/1179/2018-NUT, 5/9/1179/2018-NUT, 5/9/1179/2018-NUT, 5/9/1179/2018-NUT, 5/9/1179/2018-NUT, 5/9/1179/2018-NUT)
This publication has 28 references indexed in Scilit:
- Problems and Challenges to Adaptation of Gluten Free Diet by Indian Patients with Celiac DiseaseNutrients, 2013
- Gluten contamination of naturally gluten-free flours and starches used by Canadians with celiac diseaseFood Additives & Contaminants: Part A, 2013
- Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large cross-sectional studyBMC Gastroenterology, 2013
- Mucosal healing and mortality in coeliac diseaseAlimentary Pharmacology & Therapeutics, 2012
- Gluten contamination in the Canadian commercial oat supplyFood Additives & Contaminants: Part A, 2011
- Limited availability and higher cost of gluten‐free foodsJournal of Human Nutrition and Dietetics, 2011
- Gluten Contamination of Grains, Seeds, and Flours in the United States: A Pilot StudyJournal of the American Dietetic Association, 2010
- Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten‐free dietAlimentary Pharmacology & Therapeutics, 2009
- Advances in Celiac Disease and Gluten-Free DietJournal of the American Dietetic Association, 2008
- Persistent small bowel mucosal villous atrophy without symptoms in coeliac diseaseAlimentary Pharmacology & Therapeutics, 2007